Balance sheet of Speciality Medicines is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Speciality Medicines is decreasing.
Latest net debt of Speciality Medicines is -₹17.9 Crs as of Mar-26.
This is less than Mar-25 when it was ₹3.76 Crs.

Yes, profit is increasing.
The profit of Speciality Medicines is ₹10.87 Crs for TTM, ₹8.61 Crs for Mar 2025 and ₹2.93 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Speciality Medicines latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances